Rheumatology papers
Pofolia’s corpus holds 89 papers from Rheumatology (2012–2026), each with a short summary. Below, the 20 most-cited, then the most recently added.
At a glance
- Most cited: Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus (2012, 5,321 citations).
- The 20 papers listed have 47,482 citations between them.
- 14 of the 16 with a known journal quartile appeared in a Q1 journal.
- 10 have a free full text (open access).
- Most frequent journals: Arthritis & Rheumatology, Arthritis Care & Research, New England Journal of Medicine.
- Published between 2012 and 2023.
Most cited
Ranked by citation count. Because citations accumulate over time, this list naturally leans towards work published a few years ago; for where the field is now, see “recently added”. How to read the signals
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
Arthritis & Rheumatism · 2012 · FWCI 98.74 · 5,321 citations
New Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for lupus have been developed and validated, showing improved sensitivity and fewer misclassifications compared to previous ACR criteria.
Osteoarthritis: A disease of the joint as an organ
Arthritis & Rheumatism · 2012 · FWCI 58.57 · 3,091 citations
Osteoarthritis (OA) is reframed from a "degenerative joint disease" to a complex disease involving abnormal remodeling of all joint tissues, driven by inflammatory mediators, leading to "joint failure."
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
Arthritis Care & Research · 2012 · Q1 · SJR 1.00 · FWCI 168.89 · 3,091 citations · Open access
New guidelines from the American College of Rheumatology offer conditional and strong recommendations for managing osteoarthritis (OA) in the hand, hip, and knee, incorporating both non-pharmacologic and pharmacologic therapies.
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Arthritis & Rheumatology · 2015 · Q1 · SJR 4.00 · FWCI 215.33 · 2,792 citations
A new evidence-based guideline offers 74 recommendations for pharmacologic treatment of rheumatoid arthritis (RA), distinguishing between strong and conditional advice based on benefit-harm balance and patient preferences.
Campbell-Walsh urology
Elsevier eBooks · 2012 · FWCI 115.70 · 2,713 citations
This abstract outlines the comprehensive structure of the Campbell-Walsh Urology textbook, detailing its extensive coverage of urologic anatomy, clinical decision-making, surgical techniques, and various disease states.
IgG4-Related Disease
New England Journal of Medicine · 2012 · Q1 · SJR 18.00 · FWCI 155.25 · 2,606 citations
This review outlines the diverse range of autoimmune diseases now understood to be linked with IgG4 autoantibodies.
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Arthritis & Rheumatology · 2019 · Q1 · SJR 4.00 · FWCI 146.04 · 2,554 citations · Open access
New classification criteria for Systemic Lupus Erythematosus (SLE) have been developed, requiring a positive Antinuclear Antibody (ANA) test as an entry point, followed by additive weighted criteria across clinical and immunologic domains.
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee
Arthritis Care & Research · 2020 · Q1 · SJR 1.00 · FWCI 242.44 · 2,502 citations · Open access
New guidelines offer strong recommendations for exercise, weight loss, self-management programs, and tai chi for hand, hip, and knee osteoarthritis.
Diagnosis and Management of Rheumatoid Arthritis
JAMA · 2018 · Q1 · SJR 5.00 · FWCI 107.57 · 2,313 citations
Early diagnosis and treatment of Rheumatoid Arthritis (RA) can prevent irreversible joint damage and disability in up to 90% of patients. A treat-to-target strategy, aiming for remission or low disease activity within 6 months, is key to improved outcomes.
Diagnosis and Treatment of Hip and Knee Osteoarthritis
JAMA · 2021 · Q1 · SJR 5.00 · FWCI 223.03 · 2,279 citations
Hip and knee osteoarthritis (OA) are highly prevalent and disabling conditions affecting over 240 million people globally, characterized by joint pain, stiffness, and functional limitation.
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
New England Journal of Medicine · 2020 · Q1 · SJR 18.00 · FWCI 332.58 · 2,259 citations
Three critically ill patients with COVID-19 presented with coagulopathy and antiphospholipid antibodies.
Revised procedures for staining and clearing small fishes and other vertebrates for bone and cartilage study
Société Française d'Ichtyologie · 2023 · FWCI 33.33 · 1,989 citations
A new protocol for staining bone and cartilage in small vertebrates minimizes damage by altering the dehydration and deacidification steps, improving preservation of delicate structures.
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee
Arthritis & Rheumatology · 2020 · Q1 · SJR 4.00 · FWCI 169.45 · 1,959 citations · Open access
New guidelines offer strong recommendations for exercise, weight loss, self-management programs, tai chi, and specific bracing/injections for osteoarthritis (OA) of the hand, hip, and knee.
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
Arthritis Care & Research · 2012 · Q1 · SJR 1.00 · FWCI 167.03 · 1,803 citations · Open access
Updated guidelines provide recommendations for using conventional synthetic, targeted synthetic, and biologic disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis (RA) treatment.
Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021
The Lancet Rheumatology · 2023 · Q1 · SJR 6.00 · FWCI 349.41 · 1,797 citations · Open access
Osteoarthritis cases surged 132% globally from 1990 to 2020, affecting 595 million people, and are projected to increase by nearly 75% by 2050 due to population aging and growth.
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
Bone Research · 2018 · Q1 · SJR 4.00 · FWCI 97.44 · 1,775 citations · Open access
This review dissects the pathological mechanisms of rheumatoid arthritis (RA) across its four stages and discusses current and emerging pharmacologic therapies aimed at achieving disease remission.
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
New England Journal of Medicine · 2022 · Q1 · SJR 18.00 · FWCI 229.91 · 1,733 citations · Open access
Tofacitinib, a drug for rheumatoid arthritis, was found to increase the risk of major adverse cardiovascular events (MACE) and cancers compared to TNF inhibitors. The drug did not meet noninferiority criteria for safety.
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
Modern Rheumatology · 2012 · Q2 · FWCI 98.18 · 1,657 citations
New comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD) have been established, combining serum IgG4 concentration and biopsy findings.
The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
International Journal of Molecular Sciences · 2021 · Q1 · SJR 1.00 · FWCI 144.06 · 1,636 citations · Open access
Tumor Necrosis Factor Alpha (TNF-α) signaling, initially known for tumor necrosis, is now understood as a key pathological driver in autoimmune diseases due to its role in chronic inflammation.
The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis
Mediators of Inflammation · 2014 · Q2 · SJR 1.00 · FWCI 42.86 · 1,612 citations · Open access
Osteoarthritis (OA) pathogenesis involves a complex interplay of inflammatory and anti-inflammatory cytokines, with inflammatory cytokines like IL-1β and TNFα playing a key role alongside anabolic processes.
Recently added
Atherogenic lipid indices are associated with carotid intima-media thickness and local carotid stiffness parameters in spondyloarthritis: a cross-sectional study
BMC Rheumatology · 2026 · Q2
In 150 spondyloarthritis (SpA) patients, atherogenic lipid indices like non-HDL-C and AIP were independently associated with markers of carotid artery damage and stiffness (CIMT and PWV), unlike traditional LDL-C and HDL-C.
Intra-Articular Extra-Synovial Venous-Type Synovial Haemangioma of the Knee in a Young Adult: Case Report and Literature Review of This Frequently Misdiagnosed Lesion
International Journal of Surgical Pathology · 2026 · Q2
A 21-year-old man with years of recurrent knee effusions and pain was diagnosed with a venous-type synovial haemangioma, a rare vascular lesion often misdiagnosed, after imaging and surgical excision confirmed the presence of large vascular channels.
Decisional conflict regarding fertility preservation among women of reproductive age with systemic lupus erythematosus: a cross-sectional study of its level and associated factors
BMC Women s Health · 2026 · Q1 · SJR 1.00
80% of women of reproductive age with SLE experience high decisional conflict regarding fertility preservation, with poor knowledge (mean score 24/100) and low social support (mean score 26/72) being key drivers.
From Past Achievements to Future Hotspots: Bibliometric View of Influential Studies on Microfracture Research
Medicine Advances · 2026 · Q2
A bibliometric analysis of the top 100 most-cited microfracture studies reveals that randomized controlled trials (RCTs) and Level IV evidence are most common, with current research focusing on autologous chondrocyte implantation, osteochondral autograft transplantation, and arthroscopic treatment.
Effectiveness and Safety of Ultrasound-Guided Radiosynovectomy for Persistent Joint Effusion: A Retrospective Single-Center Study
Nuclear Medicine and Molecular Imaging · 2026 · Q2
Ultrasound-guided radiosynovectomy (RSV) achieved clinically significant symptom improvement in 83.8% of procedures (n=278), with 27.3% experiencing complete symptom resolution, and a low adverse event rate of 3.2% (n=345).
Investigating the association between osteoarthritis and cardiovascular disease using a standardized cardiovascular health assessment tool in a nationwide health survey
Scientific Reports · 2026 · Q1
Higher cardiovascular health (CVH) is associated with significantly lower odds of osteoarthritis (OA). Adults with moderate or high CVH had 19% and 40% lower odds of OA, respectively, compared to those with low CVH (OR 0.81, 0.60).
Development and pilot implementation of an educational program for concurrent use of non-steroidal anti-inflammatory drugs and glucocorticoids in older veterans with rheumatic diseases
BMC Rheumatology · 2026 · Q2
The ScaLable Medication Deprescribing (SLIM-D) program, an educational intervention for older veterans with rheumatic diseases, was developed and pilot-tested to optimize the safe concurrent use of NSAIDs and GCs.
Rheumatology Informatics System for Effectiveness (RISE) Registry Participation Associated with Significant Gains in Quality Measure Performance: An Interrupted Time Series Analysis
Arthritis & Rheumatology · 2026 · Q1 · SJR 4.00
Practices joining the Rheumatology Informatics System for Effectiveness (RISE) registry showed significantly greater improvement in RA functional status assessment performance (0.88 percentage points/month) compared to pre-enrollment trends.
Journals in this field
The journals that publish most of this field’s papers. Quartile (Q1–Q4), SJR and h-index are from SCImago Journal Rank; “in this field” is how many of the journal’s pooled papers belong here. What is a Q1 journal? · What is the h-index?
| Journal | Quartile | SJR | h-index | In this field | Summaries |
|---|---|---|---|---|---|
| New England Journal of Medicine | Q1 | 18.00 | 1275 | 9 | 376 |
| Arthritis and Rheumatology | Q1 | 4.00 | 373 | 6 | 9 |
| Arthritis Care and Research | Q1 | 1.00 | 207 | 6 | 8 |
| Allergy: European Journal of Allergy and Clinical Immunology | Q1 | 3.00 | 226 | 3 | 15 |
| BMC Rheumatology | Q2 | — | 29 | 3 | 3 |
| JAMA | Q1 | 5.00 | 818 | 2 | 114 |
| Proceedings of the National Academy of Sciences of the United States of America | Q1 | 3.00 | 929 | 2 | 110 |
| Journal of Orthopaedic Surgery and Research | Q1 | 1.00 | 84 | 2 | 7 |
Every journal in Rheumatology (Q1–Q4) →
Add this field to your daily feed
Pick your interests and new work in your area arrives every day, summarised. Full summaries live in the app.
Open the app